IXICO PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IXICO PLC with three other
companies in this sector in the United Kingdom:
Tissue Regenix Group PLC
sales of £816,000.00 [US$993,912.48 ]
of which 108%
was Wound Care),
(£5.06 million [US$6.17 million]
of which 40%
was Preclinical Research services), and
(£5.52 million [US$6.72 million]
IXICO PLC reported sales of £3.11 million (US$3.79 million)
September of 2016.
decrease of 0.1%
versus 2015, when the company's sales were £3.12 million.